New research showed that people with type 1 diabetes who used the Diabeloop DBLG1,  a “closed-loop” insulin delivery system at home spent a larger percentage of time in their target glucose range, and experienced fewer hypoglycemic events, compared to patients who used an “open-loop” system — their regular pump and sensor.  The Diabeloop DBLG1 system consists of a glucose sensor, a patch insulin pump and a smartphone-like device. Read more